Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
 - Shares are not adjusted for stock split.
 
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
 - Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date  | Reported DateTime  | Company | Symbol | Insider Relationship  | Shares Traded  | Average Price  | Total Amount  | Shares Owned  | Filing | 
| 2024-11-20 Sale  | 2024-11-22 4:12 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 3,650 | $25.45 | $92,893 | 319,228 (Direct)  | View | 
| 2024-10-23 Sale  | 2024-10-25 4:25 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 4,361 | $29.53 | $128,780 | 322,878 (Direct)  | View | 
| 2024-10-16 Sale  | 2024-10-18 4:28 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 2,860 | $28.79 | $82,339 | 327,239 (Direct)  | View | 
| 2024-08-21 Sale  | 2024-08-23 4:15 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 3,295 | $31.86 | $104,976 | 330,099 (Direct)  | View | 
| 2024-07-24 Sale  | 2024-07-26 4:17 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 4,015 | $27.76 | $111,456 | 333,394 (Direct)  | View | 
| 2024-07-17 Sale  | 2024-07-19 5:42 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 2,505 | $29.69 | $74,382 | 337,409 (Direct)  | View | 
| 2024-05-22 Sale  | 2024-05-24 4:10 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 3,242 | $29.65 | $96,125 | 339,914 (Direct)  | View | 
| 2024-04-24 Sale  | 2024-04-26 5:18 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 3,963 | $28.9 | $114,531 | 343,156 (Direct)  | View | 
| 2024-04-17 Sale  | 2024-04-19 6:06 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 9,827 | $29.06 | $285,554 | 347,119 (Direct)  | View | 
| 2024-02-22 Sale  | 2024-02-23 4:18 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 2,134 | $36.15 | $77,144 | 301,968 (Direct)  | View | 
| 2024-01-26 Sale  | 2024-01-29 4:12 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 3,027 | $37.92 | $114,778 | 304,102 (Direct)  | View | 
| 2023-11-22 Sale  | 2023-11-24 2:41 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 3,252 | $32.78 | $106,598 | 307,129 (Direct)  | View | 
| 2023-10-25 Sale  | 2023-10-27 4:04 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 4,107 | $34.66 | $142,349 | 310,381 (Direct)  | View | 
| 2023-08-24 Sale  | 2023-08-25 5:05 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 12,286 | $20.3 | $249,406 | 314,488 (Direct)  | View | 
| 2023-07-26 Sale  | 2023-07-27 4:33 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 3,917 | $21.63 | $84,725 | 326,774 (Direct)  | View | 
| 2023-04-25 Sale  | 2023-04-26 4:08 pm  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 2,633 | $16.29 | $42,892 | 330,691 (Direct)  | View | 
| 2023-01-26 Sale  | 2023-01-27 07:20 am  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 10,156 | $18.51 | $187,988 | 245,660 (Direct)  | View | 
| 2021-11-19 Sale  | 2021-11-19 10:08 am  | Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel  | 133,486 | $8.5 | $1,134,631 | 0 (Direct)  | View | 
| 2021-07-19 Sale  | 2021-07-20 8:45 pm  | Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel  | 3,945 | $6.45 | $25,445 | 133,486 (Direct)  | View | 
| 2021-01-05 Sale  | 2021-01-07 5:52 pm  | Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel  | 6,829 | $11.13 | $76,007 | 107,431 (Direct)  | View | 
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date  | Reported DateTime  | Exercisable Expiration  | Company | Symnbol | Insider Relationship  | Shares Traded  | Conversion Price  | Shares Owned  | Filing | 
| 2024-04-02 Option Award  | 2024-04-04 4:37 pm  | N/A 2034-04-02  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 123,701 | $0 | 425,669 (Direct)  | View | 
| 2023-04-12 Option Award  | 2023-04-14 4:24 pm  | N/A 2033-04-12  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 201,485 | $0 | 447,145 (Direct)  | View | 
| 2022-08-17 Option Award  | 2022-08-19 4:57 pm  | N/A 2032-08-17  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 282,464 | $0 | 425,464 (Direct)  | View | 
| 2022-01-28 Option Award  | 2022-01-31 5:01 pm  | N/A 2032-01-28  | Immunovant Inc. | IMVT | Levine Mark S. Chief Legal Officer  | 526,000 | $0 | 526,000 (Direct)  | View | 
| 2021-03-01 Option Award  | 2021-03-03 6:31 pm  | N/A 2031-02-28  | Flexion Therapeutics Inc | FLXN | Levine Mark S. General Counsel  | 50,000 | $0 | 157,431 (Direct)  | View |